
Organization · Venture Capital
Alethea Capital Management LLC
Alethea Capital Management LLC is a California-based SEC-registered investment adviser that focuses on public equity and selective venture capital investments, particularly in biotechnology and health technology.
Overview
What Alethea Capital Management LLC does
What Alethea Capital Management LLC is
Alethea Capital Management LLC is a California-based SEC-registered investment adviser that focuses on public equity and selective venture capital investments, particularly in biotechnology and health technology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2011
- Approximate age
- About 15 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Alethea Capital Management LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
Alethea Capital Management LLC as a funder
Investment thesis
Alethea Capital Management invests in select early-stage opportunities in biotechnology and health technology, targeting founders who take unconventional paths and nurture ideas with the potential to impact millions of lives.
Focus narrative
Alethea Capital Management invests in early-stage venture opportunities, particularly in biotechnology and health technology. The firm seeks entrepreneurial founders who pursue innovative ideas capable of positively impacting millions of lives. In addition to venture investments, Alethea also engages in domestic equity, domestic long/short, and global equity investments.
Value beyond capital
Alethea Capital Management provides strategic vision, risk management, and portfolio optimization, leveraging its experience in public markets to support portfolio companies in biotechnology and health technology.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- North AmericaUnited States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Avidity Biosciences
Portfolio context
Notable portfolio companies include PatientPartner, which raised funding in September 2024, and SEngine Precision Medicine, which received a $10 million investment in July 2022. Alethea has also had notable exits such as Avidity Biosciences.
Connected ecosystem
Continue from Alethea Capital Management LLC
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Alethea Capital Management LLC
Upseed classifies Alethea Capital Management LLC under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.